Key Quantitative Figures
- Shares dematerialized during June 2026: 0 (zero)
- Total dematerialized shares as on June 30, 2026: 6,11,05,526
- NSDL: 5,24,78,317 shares
- CDSL: 86,27,209 shares
- Total dematerialized shares as on May 30, 2026: 6,11,05,526
- NSDL: 5,39,04,650 shares
- CDSL: 72,00,876 shares
- Net change in dematerialized shares during June 2026: 0 (zero)
Dates of Action
- Reporting period: June 2026
- Reference date: June 30, 2026
- Previous reference date: May 30, 2026
- Letter signing date: July 07, 2026
- RTA certificate date: July 06, 2026
Parties Involved
- Issuer: Panacea Biotec Limited
- RTA (Registrar and Share Transfer Agent): Skyline Financial Services Pvt. Ltd. (SEBI Registered Category-1)
- Stock Exchanges: BSE Limited, National Stock Exchange of India Ltd.
- Depositories: National Securities Depository Limited (NSDL), Central Depository Services (India) Ltd. (CDSL)
Financial Impact
No financial impact disclosed. The disclosure confirms zero change in dematerialized share count during the month.
Capital Structure Impact
No change in the total number of dematerialized shares during June 2026. The overall capital structure remains unchanged with 6.11 crore shares in demat form.
Additional Documentation
Annexure-1: Certificate from Skyline Financial Services Pvt. Ltd. dated July 06, 2026, confirming demat status as of June 30, 2026.